MYX vs RCE

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

MYX

M PHARMA FPO [MYX]

51MEDIUM

RCE

RECCE LTD FPO [RCE]

40LOW

Score Breakdown

MYX RCE
Technical
51
54
Catalyst
53
62
Sentiment
50
50
Fundamental
85
23
Momentum
38
50
Risk Gate
42
45

Key Metrics

MYX Metric RCE
$233.2MMarket Cap$113.8M
291KAvg Volume (20d)323K
+2.5%Short InterestN/A
$6.50052-Week High$0.730
$2.04052-Week Low$0.310
-0.7%Daily Change-2.6%
$2.810Reference Price$0.380
-20.6%ROEN/A
-20.4%Profit MarginN/A

Active Signals

MYX Signals

●Beating the Small Ords index — relative strength of 1.29, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.6x)
●EPS estimates revised upward (+10pts)
●Near 52-week low (19% of range)
●CANSLIM I: Institutional ownership (36%)
●Deeply negative margins (-20%)

RCE Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Sitting near support — this level has held before and could attract buyers again
●Lagging the Small Ords index — relative strength of 0.80, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (0.1 quarters)
●Very high P/S ratio (116.8x)
●Revenue in sharp decline (-94%)

Ask Scout AI to compare MYX and RCE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

MYX vs VIT →NAN vs NUZ →NAN vs PCK →NAN vs PEB →NAN vs PKY →
MYX Full Analysis → RCE Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).